Aerie Pharmaceuticals, Inc.
Ophthalmic composition for treating dry eye and symptoms thereof
Last updated:
Abstract:
It is provided an ophthalmic composition, particularly formulated as eye drops, comprising a non-ionic surfactant as active ingredient, wherein the non-ionic surfactant is present in an effective amount from 0.01 to 8 weight/volume % based on the total composition, for use in treating or preventing dry eye and/or for relieving one or more symptoms and/or signs of dry eye. The ophthalmic composition exerts a rapid effect in treating dry eye symptoms and signs while having very low incidence of side effects.
Status:
Application
Type:
Utility
Filling date:
6 Mar 2020
Issue date:
1 Oct 2020